Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Privia Health Group ( (PRVA) ) is now available.
Privia Health Group, Inc. announced the acquisition of an Accountable Care Organization business from Evolent Health, Inc. The transaction, which was initially announced on September 23, 2025, was finalized on December 5, 2025, potentially enhancing Privia’s market positioning and operational capabilities.
The most recent analyst rating on (PRVA) stock is a Buy with a $27.00 price target. To see the full list of analyst forecasts on Privia Health Group stock, see the PRVA Stock Forecast page.
Spark’s Take on PRVA Stock
According to Spark, TipRanks’ AI Analyst, PRVA is a Outperform.
Privia Health Group’s strong financial performance and positive earnings call insights are the primary drivers of the score. However, the high P/E ratio and mixed technical indicators temper the overall outlook.
To see Spark’s full report on PRVA stock, click here.
More about Privia Health Group
Average Trading Volume: 821,440
Technical Sentiment Signal: Buy
Current Market Cap: $2.93B
For detailed information about PRVA stock, go to TipRanks’ Stock Analysis page.